The role of MR imaging in staging of cervical carcinoma.

Radiology ◽  
1988 ◽  
Vol 166 (3) ◽  
pp. 895-896 ◽  
Author(s):  
J K Lee
Radiology ◽  
1999 ◽  
Vol 212 (2) ◽  
pp. 395-399 ◽  
Author(s):  
P. Delia Peppercorn ◽  
Arjun R. Jeyarajah ◽  
Robert Woolas ◽  
John H. Shepherd ◽  
David H. Oram ◽  
...  

2000 ◽  
Vol 10 (2) ◽  
pp. 256-270 ◽  
Author(s):  
E. A. Boss ◽  
J. O. Barentsz ◽  
L. F. A. G. Massuger ◽  
H. Boonstra

1998 ◽  
Vol 39 (1) ◽  
pp. 163
Author(s):  
Eun Jung Lee ◽  
Won Hee Jee ◽  
Soo A Im ◽  
Ho Jong Chun ◽  
Hyun Seouk Jung ◽  
...  

1998 ◽  
Vol 8 (1) ◽  
pp. 45-49 ◽  
Author(s):  
S. Postema ◽  
P. M. T. Pattynama ◽  
C. S. P. van Rijswijk ◽  
A. van Erkel ◽  
E. R. Tjin A Ton

1997 ◽  
Vol 5 (4) ◽  
pp. 767-785
Author(s):  
Jeffrey Minkoff ◽  
Steven Stecker ◽  
Gregg Cavaliere

1999 ◽  
Vol 7 (1) ◽  
pp. 73-84
Author(s):  
Kevin D. Plancher ◽  
Charles P. Ho ◽  
Stacey S. Cofield ◽  
Randy Viola ◽  
Richard J. Hawkins
Keyword(s):  

1993 ◽  
Vol 160 (3) ◽  
pp. 525-531 ◽  
Author(s):  
M J Popovich ◽  
H Hricak ◽  
K Sugimura ◽  
J L Stern

2012 ◽  
Vol 107 (12) ◽  
pp. 1956-1962 ◽  
Author(s):  
H J M A A Zijlmans ◽  
S Punt ◽  
G J Fleuren ◽  
J B Trimbos ◽  
G G Kenter ◽  
...  
Keyword(s):  

2010 ◽  
Vol 2010 ◽  
pp. 1-3 ◽  
Author(s):  
Talvensaari-Mattila Anne ◽  
Turpeenniemi-Hujanen Taina

Background. The role of matrix metalloproteinase-2 and -9 (MMP-2, MMP-9) in matrix degradation and metastasis has been described in various tumors. Their action is inhibited by their natural tissue inhibitor molecules TIMP-1 and -2.Methods. The study population consisted of 12 squamous cervical carcinoma patients and 27 healthy volunteer control patients. MMP-9, MMP-2-TIMP-2 complex, TIMP-1, and TIMP-2 were analyzed from serum samples using enzyme-linked immunoassay (ELISA).Results. The mean levels of serum TIMP-2 and of MMP-2-TIMP-2 complex were higher in healthy controls compared to patients with a malignant tumor. Serum TIMP-2 values decreased significantly from healthy controls (median 323 g/l, range 305–342 g/l) to malignant (median 136 g/l, range 120–151 g/l) squamous cervical carcinoma patients . Also, serum proMMP2-TIMP2 complex values decreased from control patients to squamous cervical carcinoma patients .Conclusion. This paper shows that the levels of circulating TIMP-2 and that of MMP-2-TIMP-2 complex are lower in squamous cervical carcinoma patients than in healthy women.


Sign in / Sign up

Export Citation Format

Share Document